| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/10428194.2013.869802 |
| P698 | PubMed publication ID | 24283755 |
| P2093 | author name string | Baosheng Zhu | |
| Yunlong Li | |||
| P2860 | cites work | Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases | Q24534264 |
| Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription | Q24534441 | ||
| DNMT3A Mutations in Acute Myeloid Leukemia | Q27559610 | ||
| Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1 | Q27687464 | ||
| Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype | Q27824844 | ||
| Recurrent DNMT3A mutations in patients with myelodysplastic syndromes | Q27851629 | ||
| DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemia | Q27851689 | ||
| Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia | Q27851713 | ||
| Prognostic relevance of integrated genetic profiling in acute myeloid leukemia | Q27851726 | ||
| The World Health Organization (WHO) classification of the myeloid neoplasms | Q28202501 | ||
| Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group | Q28296408 | ||
| Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review | Q28301344 | ||
| Oligomerization of DNMT3A controls the mechanism of de novo DNA methylation | Q42575129 | ||
| Mutational landscape of adult ETP-ALL. | Q42580357 | ||
| DNMT3A mutations are rare in childhood acute myeloid leukemia | Q42852417 | ||
| Cooperating gene mutations in childhood acute myeloid leukemia with special reference on mutations of ASXL1, TET2, IDH1, IDH2, and DNMT3A. | Q43510818 | ||
| Mutations of the epigenetics-modifying gene (DNMT3a, TET2, IDH1/2) at diagnosis may induce FLT3-ITD at relapse in de novo acute myeloid leukemia | Q43579359 | ||
| Mutational analysis of DNMT3A gene in acute leukemias and common solid cancers | Q44022767 | ||
| Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations | Q45860675 | ||
| World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. | Q46038765 | ||
| Mammalian (cytosine-5) methyltransferases cause genomic DNA methylation and lethality in Drosophila. | Q52573989 | ||
| DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications. | Q54339696 | ||
| Acute myeloid leukemia with myelodysplasia-related changes are characterized by a specific molecular pattern with high frequency of ASXL1 mutations. | Q54514871 | ||
| Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases | Q28507226 | ||
| Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting | Q28508038 | ||
| The cancer genome | Q29547643 | ||
| Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia | Q29615735 | ||
| Mutation detection by real-time PCR: a simple, robust and highly selective method | Q33412122 | ||
| A functional polymorphism in the DNA methyltransferase-3A promoter modifies the susceptibility in gastric cancer but not in esophageal carcinoma | Q33529283 | ||
| Acute myeloid leukemia | Q33741270 | ||
| Recurrent DNMT3A R882 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome | Q34069626 | ||
| Dnmt3a is essential for hematopoietic stem cell differentiation | Q34237926 | ||
| Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease | Q34524219 | ||
| Array-based genomic resequencing of human leukemia | Q34618836 | ||
| Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia | Q34627568 | ||
| Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia | Q34630212 | ||
| Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia | Q34632784 | ||
| Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia. | Q34651312 | ||
| The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms | Q35009549 | ||
| Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group | Q35046171 | ||
| Endogenous oncogenic Nras mutation initiates hematopoietic malignancies in a dose- and cell type-dependent manner | Q35112241 | ||
| Establishment and maintenance of genomic methylation patterns in mouse embryonic stem cells by Dnmt3a and Dnmt3b. | Q35169651 | ||
| Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia | Q35249294 | ||
| Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A. | Q35346433 | ||
| Deletion of the de novo DNA methyltransferase Dnmt3a promotes lung tumor progression | Q35518564 | ||
| Frequency, onset and clinical impact of somatic DNMT3A mutations in therapy-related and secondary acute myeloid leukemia | Q35717852 | ||
| Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction | Q35848938 | ||
| Mutations in DNA methyltransferase (DNMT3A) observed in acute myeloid leukemia patients disrupt processive methylation | Q36225668 | ||
| DNMT3A Mutations in Patients with Acute Myeloid Leukemia in South Brazil | Q36413395 | ||
| DNMT3A mutations and clinical features in Chinese patients with acute myeloid leukemia | Q36707383 | ||
| Epigenetic mechanisms in AML - a target for therapy | Q37715800 | ||
| Bleeding and thrombosis in acute promyelocytic leukemia | Q38006876 | ||
| IDH mutations in acute myeloid leukemia | Q38037202 | ||
| Contribution of GATA1 dysfunction to multi-step leukemogenesis | Q38039448 | ||
| Phosphorylation of the activation loop tyrosine 823 in c-Kit is crucial for cell survival and proliferation. | Q39134604 | ||
| Autotaxin is expressed in FLT3-ITD positive acute myeloid leukemia and hematopoietic stem cells and promotes cell migration and proliferation | Q39200295 | ||
| JAK2 V617F uses distinct signalling pathways to induce cell proliferation and neutrophil activation | Q39692284 | ||
| DNMT3a plays a role in switches between doxorubicin-induced senescence and apoptosis of colorectal cancer cells | Q39703300 | ||
| Dnmt3a-dependent nonpromoter DNA methylation facilitates transcription of neurogenic genes | Q41947030 | ||
| Overexpression of wild-type or mutants forms of CEBPA alter normal human hematopoiesis. | Q42113668 | ||
| P433 | issue | 9 | |
| P921 | main subject | acute myeloid leukemia | Q264118 |
| P304 | page(s) | 2002-2012 | |
| P577 | publication date | 2014-03-07 | |
| P1433 | published in | Leukemia & Lymphoma | Q6534493 |
| P1476 | title | Acute myeloid leukemia with DNMT3A mutations | |
| P478 | volume | 55 |
| Q58797413 | Biological and clinical influences of in acute myeloid leukemia patients with mutations |
| Q49311338 | Chronic myelomonocytic leukemia with double-mutations in DNMT3A and FLT3-ITD treated with decitabine and sorafenib |
| Q36009675 | DNMT3A R882 Mutations Predict a Poor Prognosis in AML: A Meta-Analysis From 4474 Patients |
| Q64069451 | Evaluation of the impact of single-nucleotide polymorphisms on treatment response, survival and toxicity with cytarabine and anthracyclines in patients with acute myeloid leukaemia: a systematic review protocol |
| Q49993172 | INPP4B promotes cell survival via SGK3 activation in NPM1-mutated leukemia |
| Q47138733 | MGMT promoter methylation as a potential prognostic marker for acute leukemia |
| Q42143971 | Mutation Analysis of Isocitrate Dehydrogenase (IDH1/2) and DNA Methyltransferase 3A (DNMT3A) in Thai Patients with Newly Diagnosed Acute Myeloid Leukemia |
| Q57073789 | Overexpression of MYCT1 Inhibits Proliferation and Induces Apoptosis in Human Acute Myeloid Leukemia HL-60 and KG-1a Cells and |
Search more.